Clinical trial
Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina
NCT00185263 · Cardium Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT00185263 |
|---|---|
| Title | Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina |
| Official title | A Multinational Multicenter, Randomized , Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Patients With Stable Angina |
| Acronym | AGENT-4 |
| Lead sponsor | Cardium Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Stable Angina |
| Intervention type | Genetic |
| Interventions | AdF5FGF-4 vs. Placebo |
| Enrollment | 116 |
| Start date | Mar 1, 2002 |
| Primary completion | Jan 1, 2005 |
| Completion | Nov 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 6, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: